Deal Library / Pharma BD Deal Intelligence

Eisai Co., Ltd. — Pharma Deals

The Pharma Closeout tracks 3 deals, $5.6B in disclosed deal value, 2 with a post-close Outcome Score for Eisai Co., Ltd..

Median Critic Score: 80  ·  Median Outcome Score: 38

Best outcome: Eisai Co., Ltd. / Ligand Pharmaceuticals (oncology product portfolio) (41)  ·  Weakest outcome: Eisai Co., Ltd. / MGI Pharma Inc. (36)

All 3 deals

• Eisai Co., Ltd. / Ligand Pharmaceuticals (oncology product portfolio) — 2006 · $205M · Underwhelmed — fell short of the thesis.
• Eisai Co., Ltd. / MGI Pharma Inc. — 2007 · $3.9B · Underwhelmed — fell short of the thesis.
• Eisai Co., Ltd. / SEED Therapeutics Inc. — 2024 · $1.5B

← Deal Library  ·  Interactive search  ·  How we score deals